Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Saijie Zhu"'
Autor:
Xuechao Liu, Guangfeng Wang, Xianglei Yan, Haibo Qiu, Ping Min, Miaoyi Wu, Chunyang Tang, Fei Zhang, Qiuqiong Tang, Saijie Zhu, Miaozhen Qiu, Wei Zhuang, Douglas D. Fang, Zhiwei Zhou, Dajun Yang, Yifan Zhai
Publikováno v:
Cell & Bioscience, Vol 9, Iss 1, Pp 1-12 (2019)
Abstract Background Imatinib shows limited efficacy in patients with gastrointestinal stromal tumors (GISTs) carrying secondary KIT mutations. HQP1351, an orally bioavailable multikinase BCR-ABL inhibitor, is currently in clinical trials for the trea
Externí odkaz:
https://doaj.org/article/684f49e1df854ee8a1b2931e36258433
Autor:
Yifan Zhai, Asher Chanan-Khan, Shaomeng Wang, Dajun Yang, Sikander Ailawadhi, Anthony Letai, Jeremy Ryan, Caixia Li, Depei Wu, Jeanne A. Stuckey, Chao-Yie Yang, Sally Przybranowski, Donna McEachern, Mi Wang, Liu Liu, Longchuan Bai, Bing Han, James Miller, John A. Copland, Gina Ciccio, Nabanita Halder, Navnita Dutta, Yan Yin, Ping Min, Jianyong Chen, Saijie Zhu, Hengbang Wang, Guangfeng Wang, Alak Manna, Douglas D. Fang, Aneel Paulus, Jing Deng
Supplementary Tables from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93cc29265231a5604031f426cd989d83
https://doi.org/10.1158/1078-0432.22489368.v1
https://doi.org/10.1158/1078-0432.22489368.v1
Autor:
Yifan Zhai, Asher Chanan-Khan, Shaomeng Wang, Dajun Yang, Sikander Ailawadhi, Anthony Letai, Jeremy Ryan, Caixia Li, Depei Wu, Jeanne A. Stuckey, Chao-Yie Yang, Sally Przybranowski, Donna McEachern, Mi Wang, Liu Liu, Longchuan Bai, Bing Han, James Miller, John A. Copland, Gina Ciccio, Nabanita Halder, Navnita Dutta, Yan Yin, Ping Min, Jianyong Chen, Saijie Zhu, Hengbang Wang, Guangfeng Wang, Alak Manna, Douglas D. Fang, Aneel Paulus, Jing Deng
Supplementary Figures from Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee10d364e50997d25d9fc8b6127afe2e
https://doi.org/10.1158/1078-0432.22489371.v1
https://doi.org/10.1158/1078-0432.22489371.v1
Autor:
Jing Deng, Aneel Paulus, Douglas D. Fang, Alak Manna, Guangfeng Wang, Hengbang Wang, Saijie Zhu, Jianyong Chen, Ping Min, Yan Yin, Navnita Dutta, Nabanita Halder, Gina Ciccio, John A. Copland, James Miller, Bing Han, Longchuan Bai, Liu Liu, Mi Wang, Donna McEachern, Sally Przybranowski, Chao-Yie Yang, Jeanne A. Stuckey, Depei Wu, Caixia Li, Jeremy Ryan, Anthony Letai, Sikander Ailawadhi, Dajun Yang, Shaomeng Wang, Asher Chanan-Khan, Yifan Zhai
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Purpose: Development of B-cell lymphoma 2 (BCL-2)–specific inhibitors poses unique challenges in drug design because of BCL-2 homology domain 3 (BH3) shared homology between BCL-2 family members and the shallow surface of their protein–protein in
Publikováno v:
Process Biochemistry. 102:286-295
Developing novel copper-based complexes as potential chemotherapeutic agents is a great challenge in antitumor medicine. In this study, we aimed to reveal a benzimidazole-quinoline copper-based complex 1 induced antitumor activity in human gastric ca
Autor:
Saijie Zhu, Douglas D. Fang, Qiang Li, Dongmei Yang, Shoulai Gu, Shaomeng Wang, Dajun Yang, Yifan Zhai
Publikováno v:
Cancer Research. 82:3939-3939
Three core components constitute the polycomb repressive complex 2 (PRC2), a multiprotein complex that catalyzes methylation of histone H3 at lysine 27 (H3K27): (1) enhancer of zeste homolog 2 (EZH2), (2) EED, and (3) suppressor of zeste 12 protein h
Publikováno v:
Molecular Pharmaceutics. 15:97-107
Solubilization of parenteral drugs is a high unmet need in both preclinical and clinical drug development. Recently, co-amorphous drug formulation has emerged as a new strategy to solubilize orally dosed drugs. The aim of the present study is to expl
Publikováno v:
Journal of Controlled Release. 163:230-239
Previously, it was shown that microneedle-mediated transcutaneous immunization with plasmid DNA can potentially induce a stronger immune response than intramuscular injection of the same plasmid DNA. In the present study, we showed that the immune re
Publikováno v:
Cancer Biology & Therapy. 13:908-914
Gemcitabine is a deoxycytidine analog used for the treatment of a wide range of solid tumors. Its efficacy is however often reduced due to the development of resistance. Ribonucleotide reductase M1 subunit (RRM1) is a key determinant of gemcitabine r
Publikováno v:
Bioconjugate Chemistry. 23:966-980
Stimulus-sensitive micelles are attractive anticancer drug delivery systems. Herein, we reported a novel strategy to engineer acid-sensitive micelles using a amphiphilic material synthesized by directly conjugating the hydrophilic poly(ethylene glyco